Matthew Lang
General Counsel en LYELL IMMUNOPHARMA, INC. .
Cargos activos de Matthew Lang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LYELL IMMUNOPHARMA, INC. | General Counsel | 05/07/2023 | - |
| Corporate Secretary | 05/07/2023 | - |
Historial de carrera de Matthew Lang
Antiguos cargos conocidos de Matthew Lang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
United Way of the Bay Area
 United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services United Way of the Bay Area owns and operates charities. The company was founded in 1923 and is headquartered in San Francisco, CA. | Director/Board Member | 01/01/2015 | 01/01/2018 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/11/2009 | 01/07/2017 |
Dechert LLP
 Dechert LLP Miscellaneous Commercial ServicesCommercial Services Dechert LLP provides legal services. It serves the chemical, construction, finance and real estate, energy, insurance, and health sectors. The firm's practice areas include business restructuring and reorganization, commercial litigation, corporate and securities, energy, finance and real estate, financial services, mergers and acquisitions, and private equity. The company was founded in 1875 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/2002 | 01/01/2009 |
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Myovant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company is headquartered in Basel, Switzerland. | Chief Executive Officer | - | - |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Chief Administrative Officer | 22/12/2019 | - |
| General Counsel | - | - | |
| Corporate Secretary | - | - | |
| MYOVANT SCIENCES LTD. | Chief Administrative Officer | - | - |
| General Counsel | 19/07/2017 | - | |
| Corporate Secretary | 01/09/2018 | - |
Formación de Matthew Lang.
| Queen's University | Undergraduate Degree |
| The University of Pennsylvania Law School | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Canadá | 2 |
| Reino Unido | 2 |
Operativa
| General Counsel | 3 |
| Corporate Secretary | 3 |
| Chief Administrative Officer | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Dechert LLP
Dechert LLP Miscellaneous Commercial ServicesCommercial Services Dechert LLP provides legal services. It serves the chemical, construction, finance and real estate, energy, insurance, and health sectors. The firm's practice areas include business restructuring and reorganization, commercial litigation, corporate and securities, energy, finance and real estate, financial services, mergers and acquisitions, and private equity. The company was founded in 1875 and is headquartered in Philadelphia, PA. | Commercial Services |
United Way of the Bay Area
United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services United Way of the Bay Area owns and operates charities. The company was founded in 1923 and is headquartered in San Francisco, CA. | Commercial Services |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Myovant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Lang
- Experiencia
